Drug Markets/Methotrexate

Methotrexate

38 NDCs across 16 manufacturers|23 Generic,15 Brand

Methotrexate is used to treat juvenile arthritis, rheumatoid arthritis, breast neoplasms, choriocarcinoma, crohn disease and esophageal neoplasms, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Oct 11, 2013. In 2024, Medicare Part D spent $246K on Methotrexate across 238 claims for 84 beneficiaries.

Methotrexate is available as 38 NDCs from 16 manufacturers (23 generic, 15 brand), with NADAC prices from $0.65 to $960.29 per ML — the most expensive product costs about 1,489× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Active FDA drug shortage

15 Methotrexate presentations are currently listed in FDA's drug shortage database (first posted Mar 13, 2023). Shortages can move NADAC prices in the following weeks.

Total NDCs

38

23G / 15B

Manufacturers

16

competing in market

Price Spread

$0.65 – $960.29

per ML, 24 of 38 NDCs

7d Activity

16↑4↓18 flat

avg +1.9% WoW · of 38 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

38 NDCs total, 38 shown

WatchDrug ↕Price 7d Change ↕
RASUVO 7.5 MG/0.15 ML AUTOINJ
$960.2932
per ML
—
RASUVO 10 MG/0.2 ML AUTOINJ
$719.5675
per ML
—
RASUVO 12.5 MG/0.25 ML AUTOINJ
$569.4729
per ML
—
OTREXUP 15 MG/0.4 ML AUTO-INJ
$484.2097
per ML
—
RASUVO 15 MG/0.3 ML AUTOINJ
$481.5154
per ML
+0.24%
OTREXUP 20 MG/0.4 ML AUTO-INJ
$480.8553
per ML
—
OTREXUP 17.5 MG/0.4 ML AUTOINJ
$476.9597
per ML
—
OTREXUP 25 MG/0.4 ML AUTO-INJ
$475.8075
per ML
—
RASUVO 17.5 MG/0.35 ML AUTOINJ
$406.5300
per ML
—
RASUVO 20 MG/0.4 ML AUTOINJ
$361.5846
per ML
-0.11%
RASUVO 25 MG/0.5 ML AUTOINJ
$288.9000
per ML
-0.07%
TREXALL 10 MG TABLET
$48.1477
per EA
—
TREXALL 7.5 MG TABLET
$36.2091
per EA
—
TREXALL 5 MG TABLET
$24.0884
per EA
—
XATMEP 2.5 MG/ML ORAL SOLUTION
$21.7635
per ML
—
METHOTREXATE 50 MG/2 ML VIAL
$3.2109
per ML
+2.76%
METHOTREXATE 50 MG/2 ML VIAL
$3.2109
per ML
+2.76%
METHOTREXATE 50 MG/2 ML VIAL
$3.2109
per ML
+2.76%
METHOTREXATE 50 MG/2 ML VIAL
$1.6520
per ML
-5.59%
METHOTREXATE 50 MG/2 ML VIAL
$1.6520
per ML
-5.59%
METHOTREXATE 50 MG/2 ML VIAL
$1.2771
per ML
+1.29%
METHOTREXATE 250 MG/10 ML VIAL
$0.7020
per ML
—
METHOTREXATE 250 MG/10 ML VIAL
$0.7020
per ML
—
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
—
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
—
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
—
METHOTREXATE 1 GRAM/40 ML VIAL
$0.6450
per ML
—
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%
METHOTREXATE 2.5 MG TABLET
$0.1689
per EA
+3.53%

Frequently Asked Questions

What is Methotrexate used to treat?

Methotrexate is used to treat juvenile arthritis, rheumatoid arthritis, breast neoplasms, choriocarcinoma, crohn disease and esophageal neoplasms, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Methotrexate?

In 2024, Medicare Part D spent $246K on Methotrexate across 238 claims for 84 beneficiaries.

Is Methotrexate in shortage?

Yes — FDA's drug shortage database currently lists 15 Methotrexate presentations with status "Current", first posted Mar 13, 2023.

How many Methotrexate products are on the market?

The Methotrexate drug market contains 38 NDCs from 16 manufacturers — 23 generic and 15 brand products.

What is the price range for Methotrexate?

NADAC reference prices for Methotrexate range from $0.6450 to $960.2932 per ML — the most expensive product costs about 1,489× the cheapest. 14 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Methotrexate cheaper than brand?

The average generic NADAC for Methotrexate is $1.5165 per ML, versus $477.2883 for brand-labeled products — brand versions average about 315× the generic price.

Which manufacturers make Methotrexate?

16 manufacturers list Methotrexate in NADAC. Ranked by number of NDCs, the largest are Medexus Pharma Inc. (7), Hospira Inc. (5), Antares Pharma, Inc. (4), Accord Healthcare Inc. (4), Teva Women's Health, Inc. (3).

How has the price of Methotrexate changed recently?

Over the past 7 days, 16 Methotrexate NDCs rose and 4 fell, with a market-wide average change of +1.9%.